Literature DB >> 16201079

Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors.

Toshimi Kaido1, Hideaki Oe, Akira Yoshikawa, Akira Mori, Shigeki Arii, Masayuki Imamura.   

Abstract

BACKGROUND/AIMS: Tissue factor (TF) is a transmembrane glycoprotein involved in initiating blood coagulation. TF has recently been reported to play an important role in tumor metastasis. The aim of this study was to evaluate the role and the prognostic value of TF in hepatocellular carcinoma (HCC) in long-term survivors.
METHODOLOGY: Among 275 patients who underwent curative hepatectomy for HCC, 62 patients who survived more than 5 years after surgery were retrospectively studied. TF expression was immunohistochemically examined.
RESULTS: TF was positive in 39 of the 62 patients. In patients with TF expression, the serum albumin level was significantly lower and capsular infiltration, tumor thrombus in the portal vein, and intrahepatic metastasis were more frequently shown than those without TF expression. The recurrence-free rate was significantly higher in the patients whose tissue stained negative for TF than in those whose tissue stained positive for TF. Multivariate analysis showed TF expression to be a significant and independent risk factor for recurrence. Concerning the recurrence pattern, all 23 patients with intrahepatic metastasis were TF-positive, whereas 3 out of 5 patients with multicentric carcinogenesis were TF-positive.
CONCLUSIONS: TF expression is closely associated with the tumor invasion and metastasis, and may serve as a useful prognostic factor of recurrence in HCC in 5-year survivors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201079

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.

Authors:  Joseph S Palumbo; Kathryn E Talmage; Jessica V Massari; Christine M La Jeunesse; Matthew J Flick; Keith W Kombrinck; Zhiwei Hu; Kelley A Barney; Jay L Degen
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

Review 2.  Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Semin Thromb Hemost       Date:  2019-05-16       Impact factor: 4.180

Review 3.  Tissue factor and cell signalling in cancer progression and thrombosis.

Authors:  W Ruf; J Disse; T C Carneiro-Lobo; N Yokota; F Schaffner
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

4.  Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

5.  Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement.

Authors:  Zhidi Pan; Jie Chen; Xiaodong Xiao; Yueqing Xie; Hua Jiang; Baohong Zhang; Huili Lu; Yunsheng Yuan; Lei Han; Yuexian Zhou; Huifang Zong; Lei Wang; Rui Sun; Jianwei Zhu
Journal:  Acta Pharm Sin B       Date:  2021-11-03       Impact factor: 14.903

6.  MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion.

Authors:  Ge Yu; Hui Li; Xin Wang; Tao Wu; Jing Zhu; Shanjun Huang; Yuanlian Wan; Jianqiang Tang
Journal:  Mol Cell Biochem       Date:  2013-05-12       Impact factor: 3.396

7.  Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.

Authors:  Gregory C Connolly; Rui Chen; Ollivier Hyrien; Parvez Mantry; Adel Bozorgzadeh; Peter Abt; Alok A Khorana
Journal:  Thromb Res       Date:  2007-11-28       Impact factor: 3.944

8.  Tissue factor expression predicts outcome in children with neuroblastoma: A retrospective study.

Authors:  Laila M Sherief; Tamer H Hassan; Marwa Zakaria; Manar Fathy; Elia A Eshak; Marwa A Bebars; Asmaa Esh
Journal:  Oncol Lett       Date:  2019-10-30       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.